Table 3.

Immunosuppression for patients with MLN nonresponsive to first-line treatment. Values are n (%).

VariablesCYCMMFAZACNIRTXNone
MLN with NS
  Pediatric rheumatologists, n = 5618 (32)14 (25)6 (11)17 (30)17 (30)1 (2)
  Pediatric nephrologists, n = 569 (16)16 (29)0 (0)15 (27)18 (32)2 (4)
MLN without NS
  Pediatric rheumatologists, n = 5210 (22)22 (45)7 (12)16 (31)13 (25)2 (8)
  Pediatric nephrologists, n = 556 (11)26 (47)1 (2)11 (20)9 (16)5 (9)
  • MLN: membranous lupus nephritis; NS: nephrotic syndrome; CYC: cyclophosphamide; MMF: mycophenolate; AZA: azathioprine; CNI: calcineurin inhibitors; RTX: rituximab.